The story of Viagra presents a challenging picture for shareholders. While the initial release generated massive profits, the lapse of its patent opened the door to off-brand alternatives, dramatically eroding market https://bookmarklethq.com/story21611423/the-copyright-and-big-pharma-a-risky-opportunity